S MART EETING NESTHESIA ESUSCITATION IN ENSIVE CARE - PRELIMINARY PROGRAM - Start Promotion
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
SMART MEETING ANESTHESIA RESUSCITATION INTENSIVE CARE
PRELIMINARY PROGRAM
ENDORSED BY
Sociètà di Anestesia e Rianimazione
Neonatale e Pediatrica Italiana
SMART MEETING ANESTHESIA RESUSCITATION INTENSIVE CARE
www.smartonweb.org
SMART - SCIENTIFIC BOARD
M. Antonelli, A. Braschi, G. Conti, L. Gattinoni,
A. Pesenti, M. Quintel, F. Raimondi, M. Senturk
SMART - SCIENTIFIC SECRETARIAT
G. Bellani, L. Brazzi, M. Girardis
SMART - ORGANIZING SECRETARIAT
Start Promotion Srl - Provider ECM 622
Via Mauro Macchi, 50 - 20124 Milano - Italy
Tel. +39 02 67071383 | Fax +39 02 67072294
Email: info@startpromotion.it | www.startpromotion.it
Tentative Faculty 6 Preliminary Program 10 Smart Nursing 19, 21 Lunch Sessions 26 Meet the Expert Sessions 28 Simulation Sessions 30 Technical Forum 36 General Information 42 Metro Network 50 Informazioni Generali 52
T E N TA T I V E FA C U LT Y T E N TA T I V E FA C U LT Y
Albrecht E., Lausanne (CH) Collino F., Milano Gori A., Milano Mattiussi E., Udine Pittiruti M., Roma Szuldrzyński K., Krakow (PL)
Amirfarzan H., Boston (USA) Colombo D., Borgomanero Grasselli G., Milano Mauri T., Milano Preiser J.C., Bruxelles (B)
Antonelli M., Roma Coniglio C., Bologna Grieco D.L., Roma McNicholas B., Galway (IRL) Protti A., Milano Talmor D., Boston (USA)
Antonini V.M., Parma Constantin J.M., Paris (F) Grillo Padilha K., Sao Paulo (BR) Meissner K., Goettingen (D) Tavazzi G., Pavia
Artoni A., Milano Conti G., Roma Grossi E., Milano Mertes P.M., Strasbourg (F) Quintel M., Goettingen (D) Tesoro S., Perugia
Azoulay E., Paris (F) Corradi F., Pisa Guarracino F., Pisa Michard F., Lausanne (CH) Thille A.W., Poitiers (F)
Cortegiani A., Palermo Guitton C., Le Mans (F) Mistraletti G., Milano Rachedi N., Roma Timsit J.F., Paris (F)
Badenes R., Valencia (E) Cremer O., Utrecht (NL) Mitzner S., Rostock (D) Ranieri V.M., Bologna Tonetti T., Bologna
Bambi S., Firenze Helbok R., Innsbruck (A) Mojoli F., Pavia Rasmussen T.E., Bethesda (USA) Torrano V., Milano
Bandera A., Milano De Ferrari G., Torino Heunks L., Amsterdam (NL) Molnar Z., Pécs (HU) Reintam Blaser A., Lucerne (CH) Torres A., Barcelona (E)
Bassetti M., Genova De Luca D., Paris (F) Hutin A., Paris (F) Mongodi S., Pavia Ristagno G., Milano
Behr A., Padova De Pascale G., Roma Monnet X., Paris (F) Robba C., Genova Vergallo A., Brescia
Bellani G., Monza De Waele J., Ghent (B) Imazio M., Torino Montrucchio G., Torino Romagnoli S., Firenze Viale P., Bologna
Berger M.M., Lausanne (CH) Di Benedetto F., Modena Ince C., Rotterdam (NL) Mossetti V., Torino Romano S.M., Firenze Vieillard-Baron A., Paris (F)
Berger M., Durham (USA) Disma N., Genova Ingelmo P.M., Montreal (CDN) Muiesan P., Birmingham (UK) Rubino A., Cambridge (UK) Villar J., Las Palmas Gran Canaria (E)
Borrometi F., Napoli Iozzo P., Palermo Mussa B., Torino Rubio I., Jena (D) Vimercati S., Monza
Bouchez S., Ghent (B) Elli S., Monza Russo G., Lodi Vincent J.L., Bruxelles (B)
Bouhemad B., Dijon (F) Engelhardt T., Montreal (CDN) Johnston D., Belfast (UK) Nordberg P., Stockholm (S) Russotto V., Monza Volta C.A., Ferrara
Bouzat P., Grenoble (F) Ercole A., Cambridge (UK) Jonsson Fagerlund M., Stockholm (S) Noto A., Messina
Brochard L., Toronto (CDN) Sacchi M., Milano Ware L.B., Nashville (USA)
Brodie D., New York (USA) Fanelli A., Bologna Kellum J., Pittsburgh (USA) Olusanya S., London (UK) Sandroni C., Roma Wik L., Oslo (N)
Brunkhorst F.M., Jena (D) Fassl J., Dresden (D) Kunst G., London (UK) Sangalli F., Milano Woolley T., Birmingham (UK)
Bruyneel A., La Louvière (B) Ferguson N.D., Toronto (CDN) Palmieri P., Milano Scelsi S., Genova
Bugada D., Bergamo Ferrando Ortolà C., Barcelona (E) Lamperti M., Abu Dhabi (UAE) Panigada M., Milano Schultz M., Amsterdam (NL) Zanella A., Milano
Ferrer R., Barcelona (E) Langer T., Milano Pasero D., Sassari Scolletta S., Siena Zanierato M., Torino
Caironi P., Torino Fontana C., Roma Lascarrou J.B., Nantes (F) Pasticci I., Milano Senturk M., Istanbul (TR)
Camporota L., London (UK) Foti G., Monza Lingsma H.F., Rotterdam (NL) Payen D., Paris (F) Servadei F., Milano
Cappelleri G., Bergamo Froulund Jensen J., Holbaek (DK) Locatelli C.A., Pavia Pea F., Udine Shankar Hari M., London (UK)
Cardoso F.S., Lisbon (P) Fumagalli R., Milano Lönnqvist P.A., Stockholm (S) Pellis T., Pordenone Singer M., London (UK)
Caricato A., Roma Futier E., Clermont-Ferrand (F) Lucchini A., Monza Pelosi P., Genova Singh Y., Cambridge (UK)
Cariou A., Paris (F) Pesenti A., Milano Skrifvars M., Helsinki (F)
Carron M., Padova Galazzi A., Milano Maggiore S.M., Chieti Petrini F., Chieti-Pescara Sorbello M., Catania
Cecconi M., Milano Gallani M.C., Laval (CDN) Malbrain M.L.N.G., Bruxelles (B) Pham T., Paris (F) Stehle P., Bonn (D)
Chiumello D., Milano Gattinoni L., Goettingen (D) Marczin N., London (UK) Piccioni F., Milano Stocchetti N., Milano
Citerio G., Monza Girardis M., Modena Marini J.J., St. Paul (USA) Pickkers P., Nijmegen (NL) Strachan J., Milton Keynes (UK)
Cohen E., New York (USA) Giussani C., Monza Mascheroni D., Milano Piquilloud L., Lausanne (CH) Strandenes G., Bergen (NO)
6 7
PRELIMINARY PROGRAM
All the scientific sessions will be in English with simultaneous EDUCATIONAL ACCREDITATION OF THE 31th SMART
translation to Italian, except for Italian Track sessions (see below). Applications will be made to both the Italian AGENAS and the European EACCME® for ECM
Tutte le sessioni scientifiche saranno in lingua inglese con traduzione and EACCME® accreditation of the 31th SMART Meeting. Attendance to the meeting will
simultanea in italiano, ad eccezione delle sessioni Italian Track (vedi entitle participants to obtain:
sotto).
- Italian credits (ECM)
according to the criteria set by the Commissione Nazionale per la Formazione Continua
ITALIAN TRACK - European credits (ECMEC®)
Sessions labelled with this icon will be in Italian only. according to the criteria set by the European Accreditation Council for Continuing
No simultaneous translation will be provided. Medical Education (EACCME®), which is an institution of the European Union of Medical
Specialists (UEMS).
Le sessioni contrassegnate da questa icona saranno esclusivamente
in italiano. Non è prevista traduzione simultanea.
ACCREDITAMENTO FORMATIVO DEL 31° SMART
Per il 31° SMART sarà richiesto l’accreditamento formativo sia nel sistema italiano (ECM) sia nel sistema
europeo (EACCME®/UEMS). Pertanto, la partecipazione al convegno potrà dare diritto al conseguimento
di:
- Crediti formativi italiani (ECM)
secondo i criteri stabiliti dalla Commissione Nazionale per la Formazione Continua
- Crediti formativi europei (ECMEC®)
secondo i criteri stabiliti dall’European Accreditation Council for Continuing Medical
Education (EACCME®), un’istituzione dell’European Union of Medical Specialists (UEMS).
p R E L I M I N A RY p r o g r a m W e d n e s d ay D E C E M B E R 9 M O RNING p R E L I M I N A RY p r o g r a m W e d n e s d ay D E C E M B E R 9 M OR N I N G
HOT TOPICS IN CARDIAC TAILORING THERAPEUTIC STRATEGIES SEPSIS CODE FROM ED TO THE ICU HOT TOPICS IN PEDIATRIC HOT TOPICS IN SMART TUTORIALS 1 REGIONAL ANESTHESIA
INTENSIVE CARE IN ACUTE BRAIN INJURY GUIDED BY... ANESTHESIA CARDIOTHORACIC Coordinator: TBD
IN THE DAILY CLINICAL
Chairpersons: TBD, TBD
ANESTHESIA PRACTICE
Chairpersons: A. Rubino, F. Sangalli Chairpersons: G. Citerio, R. Helbok Chairpersons: N. Disma, S. Tesoro
9.00 Are clinical signs enough? Chairpersons: 9.00 Respiratory physiology: Chairpersons:
9.00 Pharmacological or mechanical 9.00 Pupillometry M. Girardis 9.00 Reduction of risk in N. Marczin, D. Pasero the essential to manage R. Erskine, G. Russo
circulatory support in cardiogenic C. Robba pediatric anesthesia: a critical patient
shock? 9.20 Antibiotic strategy: always fast what should we know, 10.00 Tubeless thoracic surgery: L. Heunks 9.00 Chest wall plane blocks
S. Bouchez 9.20 Brain ultrasound and furious? what should we do myth or reality? and cancer breast
P. Bouzat J. De Waele N. Disma E. Cohen 9.30 Setting and monitoring surgery: evidence
9.20 Organ dysfunction after LVAD mechanical ventilation and outcomes
implantation 9.40 ICP-derived parameters 9.40 Saline or balanced? 9.20 Pediatric difficult airway: 10.20 When is 3D echo in the restrictive patient D. Johnston
N. Marczin G. Citerio Albumin is better what to avoid essential, when useful, G. Foti
P. Caironi T. Engelhardt when it’s a waste of time? 9.20 Abdominal wall blocks:
9.40 Hemodynamic and arterial elastance 10.00 Brain tissue oxygenation J. Fassl 10.00 Setting and monitoring should we give up
by pulse contour in patients 10.00 Vasopressors: myths and evidences 9.40 Perioperative fluid mechanical ventilation the epidural?
N. Stocchetti
undergoing light sedation for TAVI TBD management in children: 10.40 Neuromonitoring in the obstructive patient D. Bugada
S.M. Romano 10.20 qEEG can we sum it all up now? and neurocognitive C.A. Volta
10.20 Source control: an essential T. Langer outcomes in cardiac 9.40 Enhanced recovery
A. Caricato
10.00 The importance of cardiovascular but overlooked treatment surgery 10.30 Reducing opioids use strategies for total
coupling in the daily management R. Ferrer 10.00 Perioperative care in G. Kunst as much as possible knee replacement
10.40 Discussion
of critically ill patients pediatric anesthesia: it’s H. Amirfarzan G. Cappelleri
F. Guarracino 11.00 Coffee Break and Exhibition Visit 10.40 Discussion better if we do it together 11.00 Coffee Break and
P.M. Ingelmo Exhibition Visit 11.00 Coffee Break and 10.00 New blocks for thoracic
10.20 Arterial stiffness: assessment and 11.00 Coffee Break and Exhibition Visit Exhibition Visit surgery: a new tool?
clinical implications 10.20 Close-to-the-nerve vs. M. Senturk
S. Scolletta interfascial plane blocks:
sniper rifle vs shotgun 10.20 Regional anesthesia
10.40 Discussion P.A. Lönnqvist for outpatients:
to do or not to do?
11.00 Coffee Break and Exhibition Visit 10.40 Discussion TBD
11.00 Coffee Break and 10.40 Discussion
Exhibition Visit
11.00 Coffee Break and
Exhibition Visit
SMART TUTORIALS 2
TRAUMATIC BRAIN INJURY 2020: 11.30 - 12.30 ESP N IC En d o rs e me n t INNOVATION IN THORACIC Coordinator: TBD FASCIA PLANE BLOCKS:
CENTER-TBI ANESTHESIA FACT OR FICTION?
PRO-CON DEBATE POINT-OF-CARE
Chairpersons: C. Robba, F. Servadei SHOULD WE ALWAYS FOLLOW ULTRASOUND IN Chairpersons: TBD, TBD 11.30 High flow nasal cannula: Chairpersons:
PHYSIOLOGY TO SET BEDSIDE PICU AND NICU indications and technique D. Johnston, V. Torrano
11.30 Center-TBI: what is changing in TBI THERAPY IN OUR PATIENTS? 11.30 Protective ventilation A. Cortegiani
Chairpersons:
epidemiology and early treatment? in thoracic surgery 11.30 The cornerstone of fascia
Chairpersons: TBD, TBD G. Conti, D. De Luca
H.F. Lingsma M. Senturk 12.00 Understanding a gas plane blocks
Pro: L. Brochard 11.30 ESPNIC guidelines for
analysis: from numbers A. Behr
11.50 ICU patients: data from Center-TBI Con: P. Pelosi 11.50 Should we follow the to the respiratory and
point-of-care ultrasound
N. Stocchetti in PICU and NICU driving pressure for cardiocirculatory status 11.50 Fact
12.30 Lunch Break optimal management L. Camporota D. Johnston
Y. Singh
12.10 Extracranial complications: of OLV?
impact on outcome F. Piccioni 12.30 Lunch Break 12.10 Fiction
11.50 How to optimize the
G. Citerio use of ultrasound for A. Fanelli
vascular accesses 12.10 Bioengineered lung:
12.30 Lunch Break is that the future? 12.30 Lunch Break
M. Pittiruti
E. Cohen
12.10 Lung ultrasound in
pediatric critical care: 12.30 Lunch Break
where are we?
D. De Luca
12.30 Lunch Break
10 11
p R E L I M I N A RY p r o g r a m W e d n e s d ay D E C E M B E R 9 A FTE RNO O N p R E L I M I N A RY p r o g r a m W e d n e s d ay D E C E M B E R 9 A F T ER N OON
VENOARTERIAL ECMO ISCHEMIC STROKE EXTRACORPOREAL THERAPIES WHAT’S NEW IN PAIN ULTRASOUND IS MY SMART TUTORIALS 3 ANESTHESIA AND
Chairpersons: D. Brodie, F. Guarracino Chairpersons: C. Giussani, N. Stocchetti IN SEPSIS THERAPY BEDSIDE TOOL FOR… Coordinator: TBD COGNITION
Chairpersons: TBD, TBD Chairpersons: PART 1 Chairpersons: TBD, TBD
14.30 E-CPR: where are we going? 14.30 Anesthesia and intensive care F. Borrometi, P.M. Ingelmo Chairpersons: 14.30 The mechanical power
A. Hutin for acute ischemic stroke 14.30 Cytokine removal TBD, TBD as a target for VILI 14.30 Anesthesiologist’s guide
P. Bouzat C. Ince 14.30 Opioid effect and side prevention to monitor the brain
14.50 Monitoring during VA-ECMO effect variability 14.30 Neuromonitoring F. Collino H. Amirfarzan
F. Sangalli 14.50 Ischemic stroke 2020: 14.50 Endotoxin removal K. Meissner C. Robba
more and more aggressive M. Antonelli 15.00 Cardiocirculatory 14.50 Perioperative
15.10 Extracorporeal organ support with treatments 14.50 Opiod-sparing anesthetic 14.50 Pain management physiology: the essential neurocognitive
for DCD: perspective and limits R. Helbok 15.10 An international registry on the strategies G. Russo to manage a critical disorders and Alzheimer’s
M. Sacchi use of extracorporeal absorption E. Albrecht patient disease
15.10 Mechanical ventilation F. M. Brunkhorst 15.10 Lung monitoring D. Payen M. Berger
15.30 DCD heart retrieval and in stroke patients: 15.10 Can we prevent chronic S. Mongodi
transplantation is there a consensus? 15.30 A bioreactor for immune support postsurgical pain with 15.30 Cardiac output 15.10 Intraoperative EEG
A. Rubino C. Robba S. Mitzner regional anesthesia? 15.30 Hemodynamic measurement techniques monitoring and depth of
V. Mossetti management S. Scolletta sedation
15.50 Discussion 15.30 Decompressive craniectomy 15.50 Discussion G. Tavazzi H. Amirfarzan
for ischemic stroke: is it worth doing? 15.30 How are you going to 16.00 Break and Exhibition Visit
16.00 Break and Exhibition Visit C. Giussani 16.00 Break and Exhibition Visit treat persistent chronic 15.50 Discussion 15.30 Best practices for
postsurgical pain? postoperative brain
15.50 Discussion P.M. Ingelmo 16.00 Break and Exhiition Visit health and outcomes in
older adults
16.00 Break and Exhibition Visit 15.50 Discussion M. Berger
16.00 Break and Exhibition Visit 15.50 Discussion
16.00 Break and Exhibition Visit
IMPROVING ORGAN AVAILABILITY NOVEL ASPECTS OF ANALGOSEDATION ARTERIAL PRESSURE MONITORING: 16.30 - 18.00 ULTRASOUND IS MY SMART TUTORIALS 4 CONTROVERSIES IN
FOR TRANSPLANT IN THE ICU WHERE AND HOW? BEDSIDE TOOL FOR… GENERAL ANESTHESIA
ROUND DISCUSSION Coordinator: TBD
Chairpersons: TBD, TBD Chairpersons: TBD, TBD Chairpersons: TBD, TBD WHICH PEEP AND WHY? PART 2 Chairpersons:
Chairpersons: 16.30 Correct use of K. Meissner, F. Petrini
16.30 What can we do? 16.30 Dexmedetomidine for sedation
Chairperson: cardiovascular drugs
16.30 MAP-targeted fluid resuscitation TBD, TBD
in the ICU L. Gattinoni in the critical patient
R. Badenes should be abandoned! 16.30 Quality and safety in the
G. Conti Z. Molnar Discussants: 16.30 Setting the ventilator F. Guarracino operating room
16.50 What we actually do G. Bellani, L. Brochard, F. Mojoli P.M. Mertes
M. Zanierato 16.50 Volatile anesthetics 16.50 Optimal arterial pressure L. Gattinoni, X. Monnet 17.00 Echocardiography in the
G. Foti in septic patients 16.50 Renal function management of septic 16.50 Is deep neuromuscular
17.10 Optimizing the lung R. Ferrer assessment shock block a standard of care?
A. Zanella 17.10 Monitoring sedation in the ICU F. Corradi G. Tavazzi M. Carron
D. Talmor 17.10 The clinical interest of arterial
17.30 Optimizing the liver elastance for the clinician 17.10 An integrated approach 17.30 Basic echocardiographic 17.10 Should we use
P. Muiesan 17.30 Epidural analgesia in the ICU D. Payen to the surgical patient evaluation of the cardiac neostigmine as reversal
J.M. Constantin B. Bouhemad function agent?
17.50 Discussion 17.30 Arterial pressure and cardiac output, F. Corradi M. Jonsson Fagerlund
17.50 Discussion just a matter of resistance? 17.30 Monitoring of weaning
TBD from mechanical 17.30 Insights from i.v.
ventilation morphine and
17.50 Discussion S. Mongodi hydromorphone
pharmacokinetics
17.50 Discussion K. Meissner
17.50 Discussion
12 13pRELIMINARY program THURSDAY December 10 M O RNING pRELIMINARY program THURSDAY December 10 M OR N I N G
WEANING FROM MECHANICHAL EXTRACORPOREAL LIFE SUPPORT: DIFFICULT INFECTIONS iFADmini SMART ENERGY AND FEEDING SMART TUTORIALS 5 NASAL HIGH FLOW OXYGEN
VENTILATION: NEW ISSUES NEW EVIDENCES IN DIFFICULT PATIENTS FLUID STEWARDSHIP ROUTE Coordinator: TBD
IN THE CLINICAL ARENA:
AND NEW SOLUTIONS? FLUID PHYSIOLOGY PATIENT CASES AND NEW
Chairpersons: TBD, TBD Chairpersons: TBD, TBD Chairpersons: TBD, TBD
9.00 Nutritional strategy INDICATIONS
Chairpersons: TBD, TBD Chairpersons: TBD, TBD
9.00 ECCO2R for COPD. 9.00 Co-infection in influenza 9.00 Glutamine: in the critically ill Chairpersons:
9.00 Where are we at with weaning? Time for a new star: the ORION study J.F. Timsit 9.00 An overview of recent why should we give it M.M. Berger M. Antonelli, T. Mauri
A snapshot from the WEAN V.M. Ranieri trials on fluid therapy P. Stehle
SAFE study 9.20 How to improve antibiotic TBD 9.30 Optimal use of antibiotics 10.00 Clinical and physiological
T. Pham 9.20 Lung recruitability in ECMO-treated effectiveness in the ICU: 9.20 Hypophosphatemia: in the ICU effects of NHF in
ARDS patients TDM approach 9.30 Introduction and a frequent J.F. Timsit tracheotomized patients
9.20 Is P0.1 clinically useful L. Camporota F. Pea interactive voting life-threatening issue S.M. Maggiore
in difficult weaning? M.L.N.G. Malbrain TBD 10.00 Basic interpretation
L. Brochard 9.40 Sedation and early mobilization 9.40 Infections in ECMO patients of acid base balance 10.20 NHF in patients
in ECMO G. Grasselli 9.50 Everything you need 9.40 Glucose control: T. Langer with postoperative
9.40 Sedation-rehabilitation: D. Brodie to know about fluid still actual? respiratory failure
a complex intervention in the ICU 10.00 Oncology and hematology patients physiology: from J.C. Preiser 10.30 Fluid management A.W. Thille
J.M. Constantin 10.00 The future of ECMO trials P. Pickkers Frank-Starling M. Cecconi
N.D. Ferguson to Guyton-Hall 10.00 Overfeeding: a killer 10.40 Combination of NHF
10.00 Role of patient-ventilator 10.20 Fungal recommendations. P. Caironi M.M. Berger 11.00 Coffee Break and and extracorporeal CO2
dyssynchrony 10.20 ECMO: is it over? What if patient is critically ill? Exhibition Visit removal in patients with
F. Mojoli D. Talmor M. Bassetti 10.10 Hemodynamic 10.20 Intermittent enteral acute asthma
monitoring and feeding the first week? G. Grasselli
10.20 The role of pendelluft in weaning: 10.40 PRO-CON DEBATE 10.40 Immunology in sepsis: fluid responsiveness J.C. Preiser
any clinical relevance? ECMO improves oxygenation report of the SMART-EGIS meeting X. Monnet 11.00 Coffee Break and
G. Bellani Pro: A. Pesenti I. Rubio 10.40 Discussion Exhibition Visit
Con: M. Quintel 10.30 Everything you need
10.40 Does mode of method matter? 11.00 Coffee Break and Exhibition Visit to know about fluid 11.00 Coffee Break and
J.J. Marini 11.00 Coffee Break and Exhibition Visit therapy: 4 D’s Exhibition Visit
- 4 indications
11.00 Coffee Break and Exhibition Visit - 4 questions
- 4 phases
M.L.N.G. Malbrain
10.50 Discussion
11.00 Coffee Break and
Exhibition Visit
RECRUITING THE LUNG ABDOMINAL ISSUES NONINVASIVE VENTILATION iFADmini SMART METABOLIC SUPPORT: SMART TUTORIALS 6 11.30 - 12.30
IN THE ICU PATIENT FLUID STEWARDSHIP WHAT AND HOW MUCH
Chairpersons: TBD, TBD Chairpersons: TBD, TBD
THE PARADIGM SHIFT
Coordinator: TBD PRO-CON DEBATE
Chairpersons: TBD, TBD Chairpersons: TBD, TBD WHAT I LIKE AND WHAT
11.30 Lung recruitment. If, when, how 11.30 Noninvasive ventilation versus IN FLUID THERAPY 11.30 It’s up to you: new I DO NOT LIKE ABOUT
N.D. Ferguson 11.30 Acute liver failure oxygen therapy in patients with Chairpersons: 11.30 Optimal feeding route bedside signals to set THE SURVIVING SEPSIS
F.S. Cardoso acute respiratory failure M.L.N.G. Malbrain, TBD in sepsis the ventilator CAMPAIGN GUIDELINES
11.50 Recruitment in ARDS: D.L. Grieco A. Reintam Blaser D. Colombo Chairpersons:
how to measure? 11.50 Abdominal infections as a sepsis 11.30 Case presentation +
R. Ferrer, M. Girardis
L. Brochard source: diagnosis and management 11.50 How to maximize the chances interactive voting 11.50 How to use indirect 12.00 Fluid management
F. Di Benedetto of NIV success? T. Langer calorimetry in hemorrhagic shock Pro: M. Antonelli
12.10 Recruiting maneuvers during G. Foti M.M. Berger T. Woolley Con: D. Payen
anesthesia: the good, the bad, 12.10 Microbiota in the ICU: 11.50 How to implement fluid
the ugly! not only a gut problem 12.10 The use of noninvasive ventilation stewardship in your ICU? 12.10 Individualized feeding 12.30 Lunch Break 12.30 Lunch Break
P. Pelosi A. Gori to facilitate weaning and early M.L.N.G. Malbrain TBD
extubation
12.30 Lunch Break 12.30 Lunch Break A.W. Thille 12.10 How to set-up a fluid 12.30 Lunch Break
guideline?
12.30 Lunch Break P. Caironi
12.30 How to guide
deresuscitation
TBD
12.50 Discussion
13.00 Lunch Break
14 15pRELIMINARY program THURSDAY December 10 A FTE RNO O N pRELIMINARY program THURSDAY December 10 A F T ER N OON
ESOPHAGEAL PRESSURE GOING ABOVE THERAPY IN THE ICU HYPOTHERMIA VS. NORMOTHERMIA NEW STRATEGIES FOR COAGULOPATHY IN SMART TUTORIALS 7 INTERACTIVE SESSION
AND PEEP TITRATION Chairpersons: TBD, TBD AFTER CARDIAC ARREST: DIFFICULT BUGS THE CRITICALLY ILL Coordinator: TBD CHALLENGING SCENARIOS
Chairpersons: TBD, TBD WHAT IS THE TARGET IN TTM? Chairpersons: Chairpersons: TBD, TBD Chairpersons:
14.30 Communication in the ICU NEW & OLD EVIDENCES M. Bassetti, M. Girardis 14.30 Perioperative R. Fumagalli, P. Pickkers
14.30 Determinants of esophageal-pleural L.B. Ware Chairpersons: G. Ristagno, C. Sandroni 14.30 Sepsis and coagulation, optimization
pressure relationship in normal man 14.30 New strategies in anything new? S. Romagnoli 14.30 Necrotising fasciitis
I. Pasticci 14.50 Rounds at the bedside: 14.30 PRO therapeutic hypothermia (33°C): identification and K. Szuldrzyński beyond first hours
we could do better the evidence from the FINNRESUSCI treatment of invasive 15.00 Sedation in the ICU G. De Pascale,
14.50 The neglected variable in mechanical J.L. Vincent and TTH48 fungal infections 14.50 Severe thrombophilia J.M. Constantin A. Bandera
ventilation: lung volumes M. Skrifvars J. De Waele in intensive care
and transpulmonary pressures 15.10 Families and patients will never walk A. Artoni 15.30 Diagnosis of cerebral 15.00 How to treat severe CAP
L. Gattinoni alone: tracheotomy in critically 14.50 CONTRA therapeutic hypothermia 14.50 Stratification of patients or cardiac death for A. Cortegiani,
ill patients in favor of normothermia (36°C): at risk for carbapenem 15.10 Antithrombin during organ donation J. De Waele
15.10 Is esophageal pressure reflective P. Pelosi the evidence from the TTM resistant infections ECMO: rationale and M. Zanierato
of pleural pressure? T. Pellis P. Viale current practice 15.30 Patients with cardiac
D. Chiumello 15.30 Fatigue in the workplace A. Protti 16.00 Break and Exhibition Visit dysfunction and sepsis
and the #fightfatigue campaign 15.10 Targeted temperature management 15.10 Empiric therapy for S. Romagnoli,
15.30 Esophageal pressure to guide PEEP J. Strachan for cardiac arrest with nonshockable the superbugs 15.30 Is there a place for F. Guarracino
titration: does it make sense? rhythm: the new evidence from the M. Bassetti antithrombin during
M. Quintel 15.50 Discussion HYPERION trial ECMO? 16.00 Break and Exhibition visit
A. Cariou 15.30 How to dose new M. Panigada
15.50 Discussion 16.00 Break and Exhibition Visit antibiotics
15.30 Early intra-arrest cooling: does it F. Pea 15.50 Discussion
16.00 Break and Exhibition Visit works? The evidence from the
PRINCESS trial 16.00 Break and Exhiition Visit
15.50 Discussion
P. Nordberg
16.00 Break and Exhiition Visit
15.50 Discussion
16.00 Break and Exhiition Visit
ELECTROLYTES IN THE ICU: PERIOPERATIVE MANAGEMENT IMPROVING CARDIOPULMONARY SEPSIS SCIENCE: PEARLS SMART TUTORIALS 8 AIRWAY MANAGEMENT IN
ANYTHING NEW? OF VENTILATION RESUSCITATION AND PITFALLS CRITICALLY ILL PATIENTS
Coordinator: TBD
Chairpersons: TBD, TBD Chairpersons: TBD, TBD Chairpersons: G. Ristagno, M. Skrifvars Chairpersons: TBD, TBD Chairpersons: TBD, TBD
16.30 How to improve
16.30 Low sodium concentration 16.30 PRO-CON DEBATE 16.30 What is quality of CPR? Much more 16.30 The 12 elements that patient-ventilator 16.30 Intubation-related
in the critically ill: when to worry? Is low tidal volume ventilation than chest compression depth, can improve outcome synchrony morbidity and mortality -
L. Gattinoni protective in anesthesia? fraction, and rate in sepsis L. Piquilloud the Intube study results
Pro: M. Schultz L. Wik J.L. Vincent V. Russotto
16.50 Electrolytes in the urine: Con: D. Mascheroni 17.00 Recreational drugs:
how to use them? 16.50 What is the best ventilation 16.50 Sepsis phenotypes: how do they affect 16.50 Role of
P. Caironi 17.10 The issue of perioperative hyperoxia strategy during CPR? a step forward to anesthesia videolaryngoscopes
C. Ferrando Ortolà G. Ristagno personalized treatments C.A. Locatelli in the ICU
17.10 Electrolytes and acid-base D. Payen J.B. Lascarrou
equilibrium: where is the linkage? 17.30 Noninvasive oxygenation support 17.10 Resuscitative endovascular balloon 17.30 Procedural sedation
T. Langer in preoperative medicine occlusion of the aorta for refractory 17.10 Has Sepsis-3 changed M. Lamperti 17.10 Does high-flow nasal
J.M. Constantin cardiac arrest my approach to septic cannula reduce
17.30 Hyperchloremic acidosis: C. Coniglio patient? intubation problems?
a new way to control it 17.50 Discussion M. Shankar Hari C. Guitton
A. Zanella 17.30 Extracorporeal cardiopulmonary
resuscitation in refractory cardiac 17.30 Sepsis and fake news: 17.30 Human factors in airway
17.50 Discussion arrest: to whom and when putting data management
M. Skrifvars in perspective M. Sorbello
M. Singer
17.50 Neurophysiology and neuroimaging 17.50 Discussion
to predict poor neurological outcome 17.50 Discussion
after cardiac arrest
C. Sandroni
18.10 Discussion
16 17pRELIMINARY program FRIDAY December 11 M O RNING pRELIMINARY program FRIDAY December 11 M OR N I N G
MECHANICAL VENTILATION UNSOLVED QUESTIONS SEPSIS BEYOND CARENZA DI ANESTESISTI ACUTE RENAL FAILURE SMART TUTORIALS 9 SMART NURSING
AND VILI IN TRAUMA THE FIRST HOUR RIANIMATORI: Chairpersons: TBD, TBD Coordinator: TBD
Chairpersons: TBD, TBD Chairpersons: Chairpersons: TBD, TBD AFFRONTIAMOLA INFECTION CONTROL IN THE ICU
C. Fontana, T.E. Rasmussen INSIEME SENZA TABÙ 9.00 AKI biomarkers 9.00 Perioperative thromboprophylaxis IL CONTROLLO DELLE INFEZIONI
9.00 Impact of PEEP on 9.00 SvO2 in septic shock: Chairpersons: B. McNicholas M. Panigada IN TERAPIA INTENSIVA
RV function 9.00 Golden hour in trauma: from early goal L. Gattinoni, A. Pesenti Chairpersons: S. Elli, E. Mattiussi
A. Vieillard-Baron is it still enough? directed therapy to 9.20 Acute kidney injury 9.30 Arterial pressure control during
N. Rachedi late(r) ScvO2 checks 9.00 I provvedimenti presi and ventilator settings general anesthesia to prevent 9.00 The burden of ICU
9.20 Reverse triggering: R. Ferrer sino ad oggi. Muoversi A. Vieillard-Baron postoperative organ damage environmental contamination
a highly prevalent 9.20 Resuscitation and nella giungla dei Decreti, E. Futier Il peso della contaminazione
dyssynchrony hemostasis: overload 9.20 Is it time for small volume Norme, DRG ecc. 9.40 PRO-CON DEBATE ambientale in terapia intensiva
L. Brochard vs under-resuscitation. and low pressure P. Palmieri Furosemide: when 10.00 Anesthesia for interventional V. Russotto
Could whole blood be approach? Funzionario Regionale and how? cardiac procedures
9.40 Why and how to measure the solution? M. Singer Pro: J. Kellum F. Guarracino 9.20 The dark side of mobile calling
respiratory effort G. Strandenes 9.15 Aspetti organizzativi Con: D. Payen in the ICU
N.D. Ferguson 9.40 When I need more: in terapia intensiva 10.30 Anaphylaxis in anesthesia Il lato oscuro dell’uso dei cellulari
9.40 Hemorragic shock: rationale for adjunctive ed esiti: i dati del GiViTi 10.20 Discussion in terapia intensiva
P.M. Mertes
10.00 Mechanical power, to tube or not to tube? therapies TBD A. Galazzi
VILI and mortality: T. Woolley P. Pickkers 11.00 Coffee Break and Exhibition Visit 11.00 Coffee Break and Exhibition Visit
what are the links? 9.30 Il punto di vista 9.40 PICC in the ICU:
10.00 Pre-hospital use 10.00 Blood purification: della Regione what role, what evidences?
T. Tonetti
of REBOA evidences and hopes TBD PICC in terapia intensiva:
in uncontrollable quale il ruolo, quali le evidenze?
10.20 Intraoperative S. Romagnoli
mechanical ventilation bleedings 9.40 Il punto di vista B. Mussa
C. Ferrando Ortolà T.E. Rasmussen 10.20 The long-term effects del Sindacato
10.00 The “chlorhexidine ICU affair”:
of sepsis A. Vergallo
Presidente Sindacato what’s new, what’s old
10.40 Discussion 10.20 Trauma care in urban M. Shankar Hari
AAROI-EMAC La questione della clorexidina in terapia
settings: when to stay
intensiva: cosa c’è di nuovo, cosa c’è di
11.00 Coffee Break and (and play) and when to 10.40 Discussion
9.50 Il punto di vista vecchio
Exhibition Visit scoop (and run)
della SIAARTI S. Bambi
TBD 11.00 Coffee Break and
Exhibition Visit F. Petrini
10.20 How can I prevent catheter related
10.40 Discussion Presidente SIAARTI
blood stream infection in 2020?
Come possiamo prevenire le infezioni del
11.00 Coffee Break and 10.00 - 11.00
circolo sanguigno associate al catetere nel
Exhibition Visit TAVOLA ROTONDA
2020?
condotta da un giornalista con la
partecipazione di un panel di esperti G. Montrucchio
e interazione con la platea
10.40 Discussion
11.00 Coffee Break and 11.00 Coffee Break and Exhibition Visit
Exhibition Visit
ACUTE RESPIRATORY TALKS ON TOMORROW 11.30 - 12.30 SMART TUTORIALS 10 HUMANIZING THE INTENSIVE
DISTRESS SYNDROME IN THE ICU LOOKING OUTSIDE THE CARE UNIT
PRO-CON DEBATE USUAL BOX: NON ISCHEMIC Coordinator: TBD
OR SIMPLY ARF? Chairpersons: TBD, TBD CARBAPENEM SPARING UMANIZZAZIONE DELLA TERAPIA INTENSIVA
CAUSES OF CARDIOGENIC
Chairpersons: TBD, TBD STRATEGY IN CRITICALLY ILL 11.30 Strategy for the difficult-to-intubate Chairpersons: S. Bambi, P. Iozzo
11.30 Social media and their
SHOCK
PATIENTS: YES, WE CAN! patient
11.30 Lessons from the role in medical education NO, IT IS RISKY! Chairpersons: TBD, TBD M. Sorbello 11.30 How to implement a nurse led
LUNG SAFE study S. Olusanya Chairpersons: TBD, TBD follow-up program
A. Pesenti 11.30 Stress cardiomyopathies Come implementare un programma di
12.00 Managing postoperative pain
11.50 The role of the apps Yes: J.F. Timsit G. Tavazzi follow-up a conduzione infermieristica
D. Bugada
11.50 Protective ventilation in in anesthesia No: P. Viale J. Froulund Jensen
non-ARDS patients: and critical care 11.50 Arrhythmogenic
12.30 Lunch Break
different rules? H. Amirfarzan 12.30 Lunch Break cardiomyopathies 11.50 ICU diary: an Italian experience
P. Pelosi G. De Ferrari ICU diary: un’esperienza italiana
12.10 Is your smartphone the S. Vimercati
12.10 The Radiographic future of physiological 12.10 Fulminant myocarditis
monitoring? M. Imazio 12.10 Intensiva 2.0: where are we now?
Assessment of Lung
Intensiva 2.0: a che punto siamo?
Edema (RALE) score, F. Michard
a new tool for 12.30 Lunch Break G. Mistraletti
quantifying pulmonary 12.30 Lunch Break
12.30 Lunch Break
edema on the chest
radiograph
L.B. Ware
Official languages for Smart Nursing:
English - Italian with simultaneous translation
12.30 Lunch Break
Lingue ufficiali per Smart Nursing:
Inglese - Italiano con traduzione simultanea
18 19pRELIMINARY program FRIDAY December 11 A FTE RNO O N pRELIMINARY program FRIDAY December 11 A F T ER N OON
ACID BASE/ELECTROLYTES ARTIFICIAL INTELLIGENCE ARDS HOT TOPICS IN THE ICU SMART TUTORIALS 11 SMART NURSING
Chairpersons: TBD, TBD AND BIG DATA Chairpersons: TBD, TBD Chairpersons: TBD, TBD Coordinator: TBD
Chairpersons: E. Grossi, A. Noto NURSING WORKLOAD IN THE ICU
14.30 Yes, again Stewart. 14.30 Dexamethasone in ARDS: 14.30 Conservative oxygen therapy during 14.30 Cardiocirculatory evaluation and IL CARICO DI LAVORO INFERMIERISTICO
But, do you remember it? 14.30 Technology for managing a successful story MV in the ICU management of the non-cardiac IN TERAPIA INTENSIVA
J. Kellum the complexity J. Villar M. Girardis surgical patient Chairpersons: K. Grillo Padilha, S. Scelsi
A. Ercole R. Fumagalli
14.50 Boston rules: what’s really 14.50 Steroids in ARDS: 14.50 Immune checkpoint inhibitors in 14.30 LECTURE
behind these numbers? 14.50 Artificial intelligence: a skeptical approach sepsis: where are we? 15.00 Management of oliguria: Updates on EISOR in DCD donors
T. Langer the way to go for Intensive Care G. Grasselli M. Shankar Hari a pragmatic approach Aggiornamenti sul supporto d’organo
Medicine J. Kellum extracorporeo (EISOR) nei donatori
15.10 Diagnosis and management M. Cecconi 15.10 Steroids in pneumonia 15.10 New therapy‑related life‑threatening in morte cardiocircolatoria (DCD)
of hypernatremia in the ICU A. Torres toxicity in patients with malignancies. 15.30 Challenges in pre-hospital trauma V.M. Antonini
TBD 15.10 PRO-CON DEBATE What the intensivist should know management
Is research from Big Data reliable? 15.30 Steroids and Vitamin C in ALI/ARDS: E. Azoulay T.E. Rasmussen 14.50 How to score NAS:
15.30 Potassium everywhere: Pro: J.F. Timsit a word of wisdom an updated guideline
intravenous fluids in renal failure Not sure: O. Cremer J.J. Marini 15.30 Discussion Come utilizzare la scala NAS (Nurse
P. Caironi Con: M. Girardis Activity Score): una guida aggiornata
15.50 Discussion E. Mattiussi
15.50 Discussion
15.10 The evaluation of nursing workload
in an Italian ECMO Center
La valutazione del carico di lavoro
infermieristico in un Centro ECMO
italiano
A. Lucchini
15.30 Multicenter study results of NAS
and Nurse Sensitive Outcomes
in 2017
Risultati di uno studio multicentrico su
NAS e Nursing Sensitive Outcomes
nel 2017
K. Grillo Padilha
15.50 Pilot experiences with NAS in the
CHU de Québec and IUCPQ
Esperienze pilota con il NAS nel Centre
Hospitalier Universitarie (CHU) e
nell’Institut Universitaire de Cardiologie
et de Pneumologie de Québec (IUCPQ)
M.C. Gallani
16.10 Prospective study in 15 hospitals
in Belgium
Studio prospettico in 15 ospedali
del Belgio
A. Bruyneel
Official languages for Smart Nursing:
English - Italian with simultaneous translation
Lingue ufficiali per Smart Nursing:
Inglese - Italiano con traduzione simultanea
20 21NON ACCREDITED SESSIONS
Lunch Sessions, Meet the Expert Sessions, Simulation Sessions,
Technical Forums and Smart Lab
are NOT subjected to ECM/EACCME ® accreditation.
No ECM and no ECMEC ® credits can be claimed for attending these sessions.
SESSIONI NON ACCREDITATE
Lunch Session, Meet the Expert, Simulation Session, Technical Forum e Smart Lab
NON rientrano nel percorso di accreditamento ECM/EACCME ® e pertanto
non danno diritto ad alcun credito formativo italiano (ECM) né europeo (ECMEC ®).
Language: English or Italian, no simultaneous translation.
Lingua: Inglese o Italiano, senza traduzione simultanea.T E N TA T I V E FA C U LT Y - N O N A C C R E D I T E D S E S S I O N S
Albaladejo P., Grénoble (F) Donati A., Ancona Meineri M., Leipzig (D)
Antonini V.M., Parma Mojoli F., Pavia
Foti G., Monza
Arisi E., Pavia Mondino M., Milano
Fumagalli R., Milano
Montrucchio G., Torino
Badenes R., Valencia (E)
Gattinoni L., Goettingen (D) Muret J., Paris (F)
Bouhemad B., Dijon (F)
Girardis M., Modena
Brazzi L., Torino Panigada M., Milano
Gori A., Milano
Pea F., Udine
Caironi P., Torino Grasso S., Bari
Cardillo M., Centro Nazionale Trapianti Grieco D.L., Roma Rachedi N., Roma
Carron M., Padova Rasmussen T.E., Bethesda (USA)
Iapichino G., Milano
Cecchetti C., Roma Rezoagli E., Monza
Cecconi M., Milano Kellum J., Pittsburgh (USA) Rubino A., Cambridge (UK)
Chiumello D., Milano
Langer T., Milano Sangalli F., Milano
Coniglio C., Bologna
Szuldrzyński K., Krakow (PL)
Cortese G., Torino Maggiorini M., Zurich (CH)
Malbrain M.L.N.G., Bruxelles (B) Thille A.W., Poitiers (F)
Marudi A., Modena Timsit J.F., Paris (F)
Viaggi B., Firenze
Viale P., Bologna
Vincent J.L., Bruxelles (B)
Zanierato M., Torino
24LUNCH SESSIONS
DECEMBER 9 DECEMBER 10 DECEMBER 11
12.45 - 14.15 12.45 - 14.15 12.45 - 14.15
LUNCH SESSION LUNCH SESSION LUNCH SESSION
IS IT TIME FOR SUSTAINABILITY ORGAN DONATION AFTER ALBUMIN IN 2020
IN ANESTHESIA? CARDIAC DEATH AND BEYOND…
Supported by INTERSURGICAL Supported by GETINGE Supported by CSL BEHRING, GRIFOLS,
KEDRION BIOPHARMA
Chairpersons: P. Albaladejo, L. Brazzi Chairpersons: TBD, TBD
Chairpersons: TBD, TBD
Climate change and health Where are we?
J. Muret Where are we going? Albumin oxidation:
M. Cardillo physiological meaning
Where are we? L. Gattinoni
L. Brazzi Guidelines to improve DCD
donation: the Spanish experience Albumin as an anti-infective agent
The French experience R. Badenes A. Gori
J. Muret
Normothermic regional perfusion Iso- vs. hyper-oncotic
Sustainability in the OR M. Zanierato albumin-containing solutions
for beginners: P. Caironi
a European toolkit Practical aspects of DCD donation
P. Albaladejo A. Marudi Hypo-albuminemia as harmful
factor: cause or effect?
J.L. Vincent
26 27MEET THE EXPERT SESSIONS MEET THE EXPERT SESSIONS
Meet the Expert Sessions offer the opportunity of an informal and direct interaction between SMART
participants and recognized Experts in selected topics. They will take place in the Meet the Expert Corner,
a dedicated space in the Exhibition Area. It is an open space with 40 seats equipped with noise cancelling
earphones. Admission is free on a first come first served basis.
Le Meet the Expert Sessions offrono la possibilità di un’interazione veloce e diretta con Esperti riconosciuti su alcuni temi di
interesse. Si svolgono in uno spazio dedicato situato all’interno dell’Area Espositiva, il Meet the Expert Corner. Si tratta di uno
spazio aperto con 40 posti a sedere provvisti di auricolari per l’isolamento acustico. L’accesso è libero fino ad esaurimento posti.
MEET THE EXPERT CORNER WEDNESDAY DECEMBER 9 | 10.00 - 11.00 MEET THE EXPERT CORNER THURSDAY DECEMBER 10 | 11.30 - 12.30
Maintenance fluids in the ICU: time for a rational approach! How to manage vHAP and VAP
Fluidi di mantenimento in terapia intensiva: è ora di adottare Come gestire la vHAP e la VAP
un approccio razionale!
MODERATOR: P. Viale | EXPERTS: F. Pea, B. Viaggi Supported by
MODERATOR: TBD | EXPERTS: M. Cecconi, M.L.N.G. Malbrain
MEET THE EXPERT CORNER WEDNESDAY DECEMBER 9 | 11.30 - 12.30 MEET THE EXPERT CORNER THURSDAY DECEMBER 10 | 14.30 - 15.30
Meaning and interpretation of coagulation tests My secret tips to master noninvasive ventilation
Significato ed interpretazione dei test della coagulazione I miei trucchi segreti per diventare esperti di ventilazione non invasiva
MODERATOR: G. Iapichino | EXPERTS: M. Panigada, K. Szuldrzyński MODERATOR: D.L. Grieco | EXPERTS: G. Foti, A.W. Thille
MEET THE EXPERT CORNER WEDNESDAY DECEMBER 9 | 14.30 - 15.30 MEET THE EXPERT CORNER FRIDAY DECEMBER 11 | 10.00 - 11.00
Hemodynamics at the bedside with the Pulse Contour Cardiac Output (PiCCO) EISOR in DCD: technique(s), rationale and results
Emodinamica al posto letto con il Pulse Contour Cardiac Output (PiCCO) EISOR nel donatore in morte cardiocircolatoria: tecnica/che, razionale e risultati
MODERATOR: S. Grasso | EXPERTS: C. Cecchetti, R. Fumagalli Supported by MODERATOR: M. Zanierato | EXPERTS: V.M. Antonini, F. Sangalli
MEET THE EXPERT CORNER THURSDAY DECEMBER 10 | 10.00 - 11.00 MEET THE EXPERT CORNER FRIDAY DECEMBER 11 | 11.30 - 12.30
Prehospital REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) Dysnatremia in the ICU
Utilizzo preospedaliero del REBOA Disnatriemia in terapia intensiva
MODERATOR: N. Rachedi | EXPERTS: C. Coniglio, T.E. Rasmussen MODERATOR: T. Langer | EXPERTS: TBD, J. Kellum
28 29SIMULATION SESSIONS SIMULATION SESSIONS
Admission to Simulation Sessions is limited to max 40 participants. Pre-registration is required. See page
46 for details. SIMULATION CENTER WEDNESDAY DECEMBER 9 | 14.30 - 15.30
La partecipazione alle Simulation Sessions è a numero chiuso, max 40 partecipanti. Pre-iscrizione obbligatoria.
Dettagli a pagina 56.
3 Supported by &
SIMULATION CENTER WEDNESDAY DECEMBER 9 | 11.30 - 12.30
Simulation Session 3 SPEAKERS: M. Carron, G. Cortese
1 Supported by & AN ES T H ES I A PERIOPERATIVE MANAGEMENT OF OBESE PATIENTS
The purpose of this scenario is to discuss the main problems of the perioperative
management of obese patients. The topics of positioning on the operating table and airway
management will be addressed with particular attention to different technologies ensuring
Simulation Session 1 SPEAKERS: F. Mojoli, E. Arisi a safe transition from spontaneous breathing to anesthesia (traditional laryngoscopy,
fibrobrocoscopy, videolaryngoscopy). The topic of intraoperative management will
then be addressed, focusing on monitoring techniques and healthcare targets useful to
M ECHANIC A L OPTIMIZATION OF PATIENT-VENTILATOR SYNCHRONY DURING
guarantee an opioid-sparing anesthesia management in line with the latest international
ASSISTED VENTILATION
VENTILATION The purpose of this simulation scenario is to train attendees on how to optimize patient-
recommendations. Finally, the methods of optimizing awakening from anesthesia and safe
discharge from the operating block will be discussed, aiming at an early mobilization and
ventilator synchrony during assisted ventilation. Different scenarios of patient-ventilator adequate monitoring of the spontaneous respiratory function.
interaction will be simulated and their clinical implications will be discussed.
GESTIONE PERIOPERATORIA DEL PAZIENTE OBESO
OTTIMIZZAZIONE DELLA SINCRONIZZAZIONE PAZIENTE-VENTILATORE
Scopo di questo scenario è offrire ai partecipanti l’opportunità di confrontarsi con le
IN VENTILAZIONE ASSISTITA
principali problematiche della gestione perioperatoria del paziente obeso. Saranno illustrati il
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come sia posizionamento sul tavolo operatorio e la gestione delle vie aeree, con particolare attenzione
possibile ottimizzare la sincronizzazione paziente-ventilatore in ventilazione assistita. Saranno alle tecnologie che garantiscono un passaggio sicuro dal respiro spontaneo all’anestesia
simulati diversi scenari di interazione paziente-ventilatore e ne saranno discusse le implicazioni (laringoscopia tradizionale, fibrobrocoscopia, videolaringoscopia). Si affronterà poi la gestione
cliniche. intraoperatoria, con particolare attenzione alle tecniche di monitoraggio ed ai target assistenziali
utili a garantire una gestione anestesiologica il più possibile opioid-sparing, in linea con le più
recenti raccomandazioni internazionali. Verranno infine discusse le modalità di ottimizzazione del
risveglio dall’anestesia e della dimissione sicura dal blocco operatorio, con l’obiettivo di garantire
una mobilizzazione precoce ed un monitoraggio adeguato della funzione respiratoria spontanea.
SIMULATION CENTER WEDNESDAY DECEMBER 9 | 13.00 - 14.00
2 Supported by
SIMULATION CENTER WEDNESDAY DECEMBER 9 | 15.45 - 16.45
Simulation Session 2 SPEAKERS: G. Monti, M. Nocci
4 Supported by
CLINICAL EARLY WARNING SCORE PROTOCOLS TO EFFICIENTLY IDENTIFY Simulation Session 4 SPEAKERS: E. Rezoagli, TBD
PATIENTS AT RISK
M ONITO RING The purpose of this simulation scenario is to offer an overview of the potential benefits
that the introduction of Early Warning Score protocols can bring in term of clinical patient MEC H AN I C AL MONITORING OF PATIENT-VENTILATOR INTERACTION AT THE BEDSIDE
The purpose of this simulation scenario is to train attendees in the main parameters (numeric
outcomes and improved staff workflow. Rapid identification of patient deterioration can be
difficult by monitoring single parameters because clinical staff is alerted only after important
VEN T I LAT I ON or derived from waveform observation), which allow monitoring of various aspects of a
physiological changes. The Early Warning Score enables the healthcare professionals to patient’s ventilator interaction at the bedside, in different modes of assisted ventilation.
quickly identify patients at risk and reduce adverse events in general ward. Patients-ventilator synchrony and estimation of patient’s effort will be explored and the
most frequent abnormal findings will be simulated and their clinical implications will be
discussed.
PROTOCOLLI EARLY WARNING SCORE PER UNA EFFICIENTE IDENTIFICAZIONE
DEI PAZIENTI A RISCHIO
MONITORAGGIO DELL’INTERAZIONE PAZIENTE-VENTILATORE AL POSTO LETTO
Lo scopo di questo scenario di simulazione è fornire una visione generale dei potenziali vantaggi
legati all’introduzione dei protocolli Early Warning Score in termini di miglioramento degli outcome Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training sui principali
clinici e del flusso di lavoro del personale sanitario. La rapida identificazione del deterioramento parametri (numerici o derivati dall’osservazionen delle forme d’onda), che permettono il
delle condizioni del paziente può essere difficile se basata sul monitoraggio di singoli parametri, monitoraggio dei vari aspetti dell’interazione paziente-ventilatore al posto letto, in diverse
perché lo staff clinico viene allertato solo dopo variazioni fisiologiche importanti. L’Early Warning modalità di ventilazione assistita. Saranno analizzate la sincronizzazione paziente-ventilatore e
Score permette ai clinici di identificare rapidamente i pazienti a rischio e di ridurre gli eventi la stima dello sforzo respiratorio del paziente, saranno simulate le anomalie più frequentemente
avversi nei reparti di degenza ordinaria. riscontrate nella pratica clinica e ne saranno discusse le implicazioni cliniche.
30 31SIMULATION SESSIONS SIMULATION SESSIONS
SIMULATION CENTER THURSDAY DECEMBER 10 | 10.00 - 11.00 SIMULATION CENTER THURSDAY DECEMBER 10 | 12.45 - 13.45
5 Supported by 7 Supported by
Simulation Session 5 SPEAKERS: G. Foti, E. Rezoagli Simulation Session 7 SPEAKERS: B. Bouhemad, D. Chiumello
M ECHANIC A L ALVEOLAR RECRUITMENT AND PEEP SETTING BASED ON RESPIRATORY MEC H AN I C AL IMPROVING ARDS MANAGEMENT BASED ON RESPIRATORY MECHANICS
MECHANICS AND ULTRASOUND ASSESSMENT
VENTILATION The purpose of this simulation scenario is to train attendees in the possible approaches to
VEN T I LAT I ON The purpose of this simulation scenario is to discuss and train attendees on how the
perform alveolar recruitment maneuvers and to titrate PEEP while taking into account the assessment of respiratory mechanics, mechanical power and lung-muscle ultrasound could
data derived from respiratory mechanics. The most relevant pathologic alterations of these optimize the management of ARDS patients. Different scenarios will be considered and
parameters will be simulated and their clinical implications will be discussed. their clinical implications discussed.
RECLUTAMENTO ALVEOLARE E IMPOSTAZIONE DELLA PEEP IN BASE ALLA MECCANICA MIGLIORARE LA GESTIONE DELL’ARDS SULLA BASE DELLA MECCANICA RESPIRATORIA
RESPIRATORIA E DELLA VALUTAZIONE ECOGRAFICA
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training sui possibili approcci Lo scopo di questo scenario di simulazione è offrire ai partecipanti un’occasione di confronto
utilizzabili per realizzare manovre di reclutamento alveolare e per dosare la PEEP in base ai dati e di training su come sia possibile ottimizzare la gestione dei pazienti con ARDS attraverso la
derivati dalle misure di meccanica respiratoria. Saranno simulate le alterazioni patologiche più valutazione della meccanica respiratoria, del mechanical power e dell’ecografia del polmone e
rilevanti di questi parametri e ne saranno discusse le implicazioni cliniche del muscoli respiratori. Saranno presi in considerazione diversi scenari e ne saranno discusse le
implicazioni cliniche.
SIMULATION CENTER THURSDAY DECEMBER 10 | 11.30 - 12.30 SIMULATION CENTER THURSDAY DECEMBER 10 | 14.00 - 15.00
6 Supported by 8 Supported by
Simulation Session 6 SPEAKERS: F. Sangalli, M. Mondino, A. Rubino, M. Meineri Simulation Session 8 SPEAKERS: TBD
ULTRASO UND ADVANCED INTRAOPERATIVE ECHOCARDIOGRAPHY ULT R AS OUN D EVALUATION OF THE RESPIRATORY SYSTEM
The purpose of this simulation scenario is to help attendees understanding the role of The purpose of this simulation scenario is to train attendees on how to assess the lung and
perioperative echocardiography as a guide for mastering the complex pathophysiology of the diaphragm in a patient with respiratory failure. This will include basic technical approach to
the critically ill patient and selecting the best therapies and interventions. Problem-based lung and diaphragm ultrasound, detection and interpretation of pleural sliding, lung artefacts,
discussions and clinical scenarios will guide attendees through complex clinical situations diaphragm excursion and thickening. Examples will illustrate how to integrate ultrasound data
in an interactive way with the aim of integrating echocardiography in their daily clinical into clinical management (ventilation setting, weaning, decisionmaking for specific procedures
practice. such as pronation, bronchoscopy, recruitment maneuvers).
ECOCARDIOGRAFIA INTRAOPERATORIA AVANZATA VALUTAZIONE DEL SISTEMA RESPIRATORIO
Lo scopo di questo scenario di simulazione è guidare i partecipanti a riconoscere il ruolo della Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come valutare
ecocardiografia perioperatoria come guida per comprendere la complessa fisiopatologia del il polmone e il diaframma in un paziente con insufficienza respiratoria. Il training comprenderà
paziente critico ed adottare gli interventi terapeutici più indicati. Situazioni cliniche complesse un approccio tecnico di base all’ecografia del polmone e del diaframma, la rilevazione e
saranno affrontate in modo interattivo coinvolgendo i partecipanti attraverso discussioni l’interpretazione di sliding pleurico, artefatti polmonari, escursione diaframmatica ed ispessimento
problem-based e scenari clinici, con l’obiettivo di integrare l’ecocardiografia nella pratica clinica del diaframma. Si illustrerà attraverso degli esempi come integrare i dati ecografici nella gestione
quotidiana. clinica (impostazione della ventilazione, svezzamento, decision-making per procedure specifiche
come pronazione, broncoscopia, manovre di reclutamento).
32 33SIMULATION SESSIONS SIMULATION SESSIONS
SIMULATION CENTER THURSDAY DECEMBER 10 | 15.30 - 16.30 SIMULATION CENTER FRIDAY DECEMBER 11 | 11.30 - 12.30
9 Supported by 11 Supported by
Simulation Session 9 SPEAKERS: G. Foti, E. Rezoagli Simulation Session 11 SPEAKERS: TBD
SETTING THE VENTILATOR DURING ASSISTED VENTILATION
M ECHANIC A L The purpose of this simulation scenario is to train attendees on how to face the main ULT R AS OUN D ULTRASONOGRAPHIC VASCULAR ACCESS
The purpose of this simulation scenario is to train attendees on how to choose the best
VENTILATION challenges encountered when ventilating a patient with increased airway resistance,
vascular access device, how to check the pertinent vascular anatomy of the patient, and
obstructive or restrictive disease, such COPD, ARDS or lung fibrosis. These will include
detection and measurement of increased airway resistance and reduced compliance. how to place a vascular device by ultrasound guide, with particular emphasis on peripherally
inserted central venous catheters (PICCs). Through a structured ad rational approach,
participants will learn how to identify abnormal states and acquire the essential skills for an
IMPOSTAZIONE DEL VENTILATORE IN VENTILAZIONE ASSISTITA effective insertion of last-generation vascular access devices.
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come affrontare
le principali problematiche che si manifestano durante la ventilazione di un paziente con una
ACCESSO VASCOLARE CON TECNICA ECOGRAFICA
aumentata resistenza delle vie aeree, una patologia ostruttiva o restrittiva, per esempio BPCO o
ARDS o fibrosi polmonare. Tra le problematiche verranno considerate la rilevazione e la misura di Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come scegliere
una aumentata resistenza delle vie aeree e di una ridotta compliance. il miglior dispositivo di accesso vascolare, come controllare l’anatomia vascolare pertinente
nei pazienti, e come posizionare un dispositivo di accesso vascolare sotto guida ecografica, in
particolare i cateteri venosi centrali ad inserzione periferica (PICC). Attraverso un approccio
strutturato e razionale, i partecipanti impareranno come identificare anomalie anatomiche
ed acquisiranno le competenze fondamentali per un efficace posizionamento dei dispositivi di
accesso vascolare di ultima generazione.
SIMULATION CENTER FRIDAY DECEMBER 11 | 10.00 - 11.00
10 Supported by &
Simulation Session 10 SPEAKERS: M. Carron, G. Cortese
ANESTHES IA PERIOPERATIVE MANAGEMENT OF OBESE PATIENTS
The purpose of this scenario is to discuss the main problems of the perioperative
management of obese patients. The topics of positioning on the operating table and airway
management will be addressed with particular attention to different technologies ensuring
a safe transition from spontaneous breathing to anesthesia (traditional laryngoscopy,
fibrobrocoscopy, videolaryngoscopy). The topic of intraoperative management will
then be addressed, focusing on monitoring techniques and healthcare targets useful to
guarantee an opioid-sparing anesthesia management in line with the latest international
recommendations. Finally, the methods of optimizing awakening from anesthesia and safe
discharge from the operating block will be discussed, aiming at an early mobilization and
adequate monitoring of the spontaneous respiratory function.
GESTIONE PERIOPERATORIA DEL PAZIENTE OBESO
Scopo di questo scenario è offrire ai partecipanti l’opportunità di confrontarsi con le
principali problematiche della gestione perioperatoria del paziente obeso. Saranno illustrati il
posizionamento sul tavolo operatorio e la gestione delle vie aeree, con particolare attenzione
alle tecnologie che garantiscono un passaggio sicuro dal respiro spontaneo all’anestesia
(laringoscopia tradizionale, fibrobrocoscopia, videolaringoscopia). Si affronterà poi la gestione
intraoperatoria, con particolare attenzione alle tecniche di monitoraggio ed ai target assistenziali
utili a garantire una gestione anestesiologica il più possibile opioid-sparing, in linea con le più
recenti raccomandazioni internazionali. Verranno infine discusse le modalità di ottimizzazione del
risveglio dall’anestesia e della dimissione sicura dal blocco operatorio, con l’obiettivo di garantire
una mobilizzazione precoce ed un monitoraggio adeguato della funzione respiratoria spontanea.
34 35TECHNICAL FORUM TECHNICAL FORUM
Technical Forums will take place in the Technical Forum Corner, a dedicated space in the Exhibition Area. It is an open
space with 50 seats equipped with noise-cancelling earphones. Admission is free on a first come first served basis. TECHNICAL FORUM CORNER THURSDAY DECEMBER 10 | 14.30 - 15.30
I Technical Forum si svolgeranno in uno spazio dedicato situato all’interno dell’Area Espositiva, il Technical Forum Corner. Si
tratta di uno spazio aperto con 50 posti a sedere provvisti di auricolari per l’isolamento acustico. L’accesso per la partecipazione
alle sessioni è libero, fino ad esaurimento posti. SPEAKERS: G. Berlot, A. Nierhaus
TECHNICAL FORUM CORNER WEDNESDAY DECEMBER 9 | 11.30 - 12.30 BEST PRACTICE FOR THE USE OF IgM-ENRICHED IMMUNOGLOBULINS
IN SEPTIC PATIENTS
IgM-enriched immonunoglobulins have beneficial effects in adults and neonates with
Supported by sepsis and septic shock even though a definitive evidence is still lacking. The aim of this
SPEAKERS: F. Sangalli, TBD
multidisciplinary discussion is to identify patients with bacterial infections who may
benefit the most by an early administration of IgM enriched immunoglobulins.
TELEVISIT IN CRITICAL CARE: SCIENCE, NOT FICTION
Remote presence solutions enable clinicians to provide real time televisits with BEST PRACTICE PER L’IMPIEGO DI IMMUNOGLOBULINE ARRICCHITE IN IgM
simultaneous patient assessment and image diagnostics. Advanced echocardiography NEI PAZIENTI SETTICI
Supported by in acute cardiovascular diseases is a topic of great interest. Feasibility and efficacy of
this approach in the management of simulated critical cases will be discussed with the Le immunoglobuline arricchite in IgM hanno effetti benefici negli adulti e nei neonati con sepsi
contributions of experienced echocardiographists. e shock settico, sebbene non siano ancora disponibili evidenze definitive. Lo scopo di questa
discussione multidisciplinare è identificare i pazienti con infezioni batteriche che possano trarre
i maggiori benefici da una somministrazione precoce di immunoglobuline arricchite in IgM.
TELEVISITA IN AREA CRITICA: SCIENZA, NON FANTASCIENZA
Le soluzioni di presenza remota consentono ai medici di eseguire una televisita, in tempo reale,
con la contemporanea valutazione di paziente e diagnostica per immagini. Un ambito di sicuro VISIT US AT BOOTH No . 13-14
interesse è quello della valutazione ecocardiografica avanzata nella patologia cardiovascolare
acuta. Con la collaborazione di esperti ecocardiografisti, valutaremo la fattibilità e l’efficacia
di un approccio attraverso tale interfaccia nella gestione di casi critici simulati.
VISIT US AT BOOTH No . 22
TECHNICAL FORUM CORNER THURSDAY DECEMBER 10 | 16.00 - 17.30
TECHNICAL FORUM CORNER WEDNESDAY DECEMBER 9 | 16.00 - 17.00 SPEAKER: G. Foti
CPAP: HELMET AND BEYOND
SPEAKERS: A. Donati, M. Girardis, G. Montrucchio
The purpose of this Technical Forum is to illustrate noninvasive CPAP as a useful tool
for the prevention of endotracheal intubation. The proper application of the technique
PATIENT MANAGEMENT IN SEPSIS AND SEPTIC SHOCK: Supported by in different conditions may prevent its failure. The appropriate equipment will be
ARE WE CLOSE TO A BREAKTHROUGH? presented, as well as monitoring and the proper interpretation of key parameters to
solve the most common problems. Experts will share their know-how on this technique.
Adrenomedullin (ADM) is a peptide whose levels have been found high in several pathological
conditions. A laboratory method is now available enabling the measurement of one of its
Supported by fragments (proADM) whose levels seem to be associated to sepsis severity so that it is
supposed to have a role as early marker. What clinical role could be played by this biomarker CPAP: ELMETTO ED OLTRE
and what answers can it provide? What role for a combined use of proADM and other Lo scopo di questo Technical Forum è illustrare la CPAP in modalità non invasiva come
biomarkers? This will be discussed with experts of the topics who have tested its applicability strumento utile alla prevenzione dell’intubazione. La corretta applicazione della tecnica
in the clinical practice. nelle svariate condizioni può prevenirne il fallimento. Saranno presentate le attrezzature più
appropriate, il monitoraggio e la corretta interpretazione dei parametri più importanti come
soluzione ai problemi più comuni. Gli esperti metteranno a disposizione le proprie conoscenze
GESTIONE DEL PAZIENTE CON SEPSI E SHOCK SETTICO: sull’utilizzo di questa tecnica.
SIAMO VICINI AD UNA SVOLTA?
L’adrenomedullina (ADM) è un peptide i cui livelli sono elevati in diversi quadri patologici. È oggi
VISIT US AT BOOTH No . 30-31 Un s er v izio d i C offee Br eak s arà of f e r t o ai par t e c ipan t i.
disponibile la misura di un suo frammento (proADM) i cui livelli appaiono correlati con la severità della
sepsi, tanto da farne ipotizzare un ruolo come marcatore precoce. Quale potrà essere il ruolo clinico per
questo biomarker e quali risposte potrà fornire? Quale ruolo per un uso combinato con altri biomarcatori?
Se ne parla con esperti del settore che ne hanno provato l’applicabilità nella pratica clinica.
VISIT US AT BOOTH No . 23 U n servi zi o di Coffee B rea k sa rà offerto a i pa rtec i pa nti .
36 37Puoi anche leggere
